Parity-induced changes in global gene expression in the human mammary gland

European Journal of Cancer Prevention

Volumn 14, Issue 2, 2005, Pages 129-137

  Verlinden, I ^a   Gungor N ^a   Wouters, K ^b   Janssens, J ^a   Raus, J ^a   Michiels, L ^a  

^a HASSELT UNIVERSITY   (Belgium)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Differentiation; First full term pregnancy; Gene expression; Mammary gland; SAGE

Indexed keywords

ADIPSIN; BETA CASEIN; CCAAT ENHANCER BINDING PROTEIN BETA; CCAAT ENHANCER BINDING PROTEIN DELTA; CYTOKERATIN 14; KAPPA CASEIN; MUCIN;

ADULT; ARTICLE; BREAST CANCER; CANCER RISK; CELL DIFFERENTIATION; CYTOSKELETON; DOWN REGULATION; EXTRACELLULAR MATRIX; FEMALE; GENE EXPRESSION PROFILING; GROWTH INHIBITION; HUMAN; HUMAN TISSUE; MAMMARY GLAND; NORMAL HUMAN; NULLIPARA; PARITY; PREGNANCY; PRIORITY JOURNAL; PROTECTION; SERIAL ANALYSIS OF GENE EXPRESSION;

ADULT; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; CYTOSKELETON; DOWN-REGULATION; FEMALE; GENE EXPRESSION PROFILING; HUMANS; MAMMARY GLANDS, HUMAN; PARITY; PREGNANCY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SALVIA OFFICINALIS; UP-REGULATION;

EID: 17144381276     PISSN: 09598278     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008469-200504000-00008     Document Type: Article

References (39)

1. Adany R, Heimer R, Caterson B, Sorrell JM, Iozzo RV (1990). Altered expression of chondroitin sulfate proteoglycan in the stroma of human colon carcinoma. Hypomethylation of PG-40 gene correlates with increased PG-40 content and mRNA levels. J Biol Chem 265: 11389-11396.
2. Beckmann MW, Niederacher D, Schnurch HG, Gusterson BA, Bender HG (1997). Multistep carcinogenesis of breast cancer and tumour heterogeneity. J Mol Med 75: 429-439.
3. Bergstraesser LM, Srinivasan G, Jones JC, Stahl S, Weitzman SA (1995). Expression of hemidesmosomes and component proteins is lost by invasive breast cancer cells. Am J Pathol 147: 1823-1839.
4. Bray F, Sankila R, Ferlay J, Parkin DM (2002). Estimates of cancer incidence and mortality in Europe in 1995. Eur J Cancer 38: 99-166.
5. Chodosh LA, D'Cruz CM, Gardner HP, et al. (1999). Mammary gland development, reproductive history, and breast cancer risk. Cancer Res 59(7 Suppl): 1765s-1771s discussion 1771s-1772s
6. Coppock DL, Kopman C, Scandalis S, Gilleran S (1993). Preferential gene expression in quiescent human lung fibroblasts. Cell Growth Differ 4: 483-493.
7. D'Cruz CM, Moody SE, Master SR, et al. (2002). Persistent parity-induced changes in growth factors, TGF-beta3, and differentiation in the rodent mammary gland. Mol Endocrinol 16: 2034-2051.
8. Disepio D, Ghosn C, Eckert R, et al. (1998). Identification and characterization of a retinoid-induced class II tumor suppressor/growth regulatory gene. Proc Natl Acad Sci USA 95: 14811-14815.
9. Ginger M, Rosen J (2003). Pregnancy-induced changes in cell-fate in the mammary gland. Breast Cancer Res 5: 192-197.
10. Graham JD, Balleine RL, Milliken JS, Bilous AM, Clarke CL (1997). Expression of osteonectin mRNA in human breast tumours is inversely correlated with oestrogen receptor content. Eur J Cancer 33: 1654-1660.
11. Guzman RC, Yang J, Rajkumar L, et al. (1999). Hormonal prevention of breast cancer: mimicking the protective effect of pregnancy. Proc Natl Acad Sci USA 96: 2520-2525.
12. Huang RP, Fan Y, de Belle I, et al. (1999). Decreased Egr-1 expression in human, mouse and rat mammary cells and tissues correlates with tumor formation. Oncogene 18: 3633-3642.
13. Iozzo RV, Murdoch AD (1996). Proteoglycans of the extracellular environment: clues from the gene and protein side offer novel perspectives in molecular diversity and function. FASEB J 10: 598-614.
14. Iozzo RV (1997). The family of the small leucine-rich proteoglycans: key regulators of matrix assembly and cellular growth. Crit Rev Biochem Mol Biol 32: 141-174.
15. Lacey JV Jr, Devesa SS, Brinton LA (2002). Recent trends in breast cancer incidence and mortality. Environ Mol Mutagen 39: 82-88.
16. MacMahon B, Cole P, Liu M, et al. (1970). Age at birth and breast cancer risk. Bull World Health Org 34: 209-221.
17. Marks PA, Rifkind RA, Richon VM, Breslow R (2001). Inhibitors of histone deacetylases are potentially effective anticancer agents. Clin Cancer Res 7: 759-760.
18. Mauviel A, Santra M, Chen YQ, Uitto J, Iozzo RV (1995). Transcriptional regulation of decorin gene expression. Induction by quiescence and repression by tumor necrosis factor-alpha. J Biol Chem 270: 11692-11700.
19. Miksicek RJ, Myal Y, Watson PH, et al. (2002). Identification of a novel breast and salivary gland-specific, mucin-like gene strongly expressed in normal and tumor mammary epithelium. Cancer Res 62: 2736-2740.
20. Munster PN, Troso-Sandoval T, Rifkind R, Marks PA, Richon VM (2001). The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces differentiation of human breast cancer cells. Cancer Res 61: 8492-8497.
21. Piquemal D, Commes T, Manchon L, et al. (2002). Transcriptome analysis of monocytic leukemia cell differentiation. Genomics 80: 361-363.
22. Porter PL, Sage EH, Lane TF, Funk SE, Gown AM (1995). Distribution of SPARC in normal and neoplastic human tissue. J Histochem Cytochem 43: 791-800.
23. Rentsch J, Chiesi M (1996). Regulation of ob gene mRNA levels in cultured adipocytes. FEBS Lett 379: 55-59.
24. Rios-Doria J, Day KC, Kuefer R, et al. (2003). The role of calpain in the proteolytic cleavage of E-cadherin in prostate and mammary epithelial cells. J Biol Chem 278: 1372-1379.
25. Rosen JM, Zahnow C, Kazansky A, Raught B (1998). Composite response elements mediate hormonal and developmental regulation of milk protein gene expression. Biochem Soc Symp 63: 101-111.
26. Russo J, Russo IH (1987). Biological and molecular bases of mammary carcinogenesis. Lab Invest 57: 112-137.
27. Russo J, Russo IH (1993). Development pattern of human breast and susceptibility to carcinogenesis. Eur J Cancer Prev 2: 85-100.
28. Russo J, Russo IH (1997). Role of differentiation in the pathogenesis and prevention of breast cancer. Endocr Relat Cancer 4: 7-12.
29. Russo J, and Russo IH (2001). The pathway of neoplastic transformation of human breast epithelial cells. Radiation 155: 151-154.
30. Russo J, Rivera R, Russo IH (1992). Influence of age and parity on the development of the human breast. Breast Cancer Res Treat 23: 211-218.
31. Santra M, Skorski T, Calabretta B, Lattime EC, Iozzo RV (1995). De novo decorin gene expression suppresses the malignant phenotype in human colon cancer cells. Proc Natl Acad Sci USA 92: 7016-7020.
32. Santra M, Mann DM, Mercer EW, et al. (1997). Ectopic expression of decorin protein core causes a generalized growth suppression in neoplastic cells of various histogenetic origin and requires endogenous p21, an inhibitor of cyclin-dependent kinases. J Clin Invest 100: 149-157.
33. Sinha DK, Pazik JE, Dao TL (1988). Prevention of mammary carcinogenesis in rats by pregnancy: Effect of full-term and interrupted pregnancy. Br J Cancer 57: 390-394.
34. Sivaraman L, Medina D (2002). Hormone-induced protection against breast cancer. J Mammary Gland Biol Neoplasia 7: 77-92.
35. Suzuki R, Atherton AJ, O'Hare MJ, et al. (2000). Proliferation and differentiation in the human breast during pregnancy. Differentiation 66: 106-115.
36. Triano EA, Slusher LB, Atkins TA et al. (2003). Class I alcohol dehydrogenase is highly expressed in normal human mammary epithelium but not in invasive breast cancer: implications for breast carcinogenesis. Cancer Res 63: 3092-3100.
37. Velculescu VE, Zhang L, Vogelstein B, Kinzler KW (1995). Serial analysis of gene expression. Science 270: 484-487.
38. Wykoff CC, Beasley N, Watson PH, et al. (2001). Expression of the hypoxia-inducible and tumor-associated carbonic anhydrases in ductal carcinoma in situ of the breast. Am J Pathol 158: 1011-1019.
39. Yang J, Yoshizawa K, Nandi S, Tsubura A (1999). Protective effects of pregnancy and lactation against N-methyl-N-nitrosourea-induced mammary carcinomas in female Lewis rats. Carcinogenesis 20: 623-628.